LQDA - Liquidia Technologies Inc logo

Liquidia Technologies Inc

LQDA

Liquidia Technologies develops, manufactures, and commercializes therapies for rare cardiopulmonary diseases, focusing on treatments for pulmonary arterial hypertension (PAH) using advanced drug delivery technology, including inhaled and injectable formulations.

โš•๏ธ Healthcare NASDAQ Listed 2018 $ USD
$1,000 invested 5 years ago โ†’$11,056today

Score Overview

1 Year
Score
Net Growth301.10%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth184.81%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score6.4
Net Growth6x
Net Trend40%
Net Income Consistencyโ€”
Rev Growth35x
Rev Trend80%
Revenue Consistencyโ€”
All Time
Score
Net Growth360.85%
Net Trend50%
Net Income Consistency
Rev Growth166x
Rev Trend75%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Liquidia Technologies Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. LQDA does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-22
$ 39.69โ€”
1 Year2025-10-22
$ 22.3477.66%
5 Years2021-10-22
$ 3.5911x
All Time2018-07-26
$ 11.10257.57%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 450M$ 138M$ 284M
2025$ 158M-$ 68M$ 190M
2024$ 13M-$ 130M$ 176M
2023$ 17M-$ 78M$ 83M
2022$ 15M-$ 41M$ 93M
2021$ 12M-$ 34M$ 57M
2020$ 739.63K-$ 59M$ 65M
2019$ 8M-$ 47M$ 55M
IPO2018$ 2M-$ 53M$ 39M
LQDA - Liquidia Technologies Inc logo

Liquidia Technologies Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 739.63K to $ 158M and net income went from -$ 59M to -$ 68M. Revenue increased in 4 of those 5 years; net income in 2.

Liquidia Technologies Inc currently holds a 5-year HDB Score of 6.4 out of 10. How the HDB Score is calculated.

Membership

Explore LQDA with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,119 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies